Analyst Reco. Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 08:12:12 2025-12-12 am EST			5-day change	1st Jan Change
105.36 ^CHF	-0.59%		-1.64%	+18.74%

07:42am	Novartis Breaks Ground on North Carolina Manufacturing Hub	MT
07:36am	Novartis Starts Construction of New Manufacturing Complex in US	MT

Analyst Reco.

AlphaValue/Baader Europe Ups Novartis Price Target on 'Strong' Execution, 'Vigorous' Growth	Dec. 08	MT
NOVARTIS AG : Upgraded to Buy by JP Morgan	Dec. 08	ZD
Swiss stocks - Factors to watch on December 8	Dec. 08	RE
Novartis raises guidance and target price after strong execution	Dec. 05
Sector Update: Health Care Stocks Higher Late Afternoon	Dec. 03	MT
Novartis Shares Rise After Morgan Stanley Upgrade	Dec. 03	MT
Morgan Stanley Upgrades Novartis to Overweight From Equal Weight, $136 Price Target	Dec. 03	MT
Janux dives as gaps in prostate cancer study data worry investors	Dec. 02	RE
Swiss stocks - Factors to watch on November 25	Nov. 25	RE
AlphaValue/Baader Europe Upgrades Novartis to Add Rating, Raises PT	Nov. 21	MT
NOVARTIS AG : Receives a Buy rating from Deutsche Bank	Nov. 21	ZD
NOVARTIS AG : Gets a Neutral rating from UBS	Nov. 21	ZD
NOVARTIS AG : Barclays reiterates its Sell rating	Nov. 21	ZD
NOVARTIS AG : Bernstein remains its Buy rating	Nov. 21	ZD
NOVARTIS AG : UBS reaffirms its Neutral rating	Nov. 20	ZD
Swiss stocks - Factors to watch on November 20	Nov. 20	RE
Swiss stocks - Factors to watch on November 19	Nov. 19	RE
Berenberg Ups Novartis Price Target Ahead of Capital Markets Day	Nov. 18	MT
NOVARTIS AG : Berenberg reaffirms its Neutral rating	Nov. 18	ZD
NOVARTIS AG : Gets a Neutral rating from JP Morgan	Nov. 12	ZD
Sector Update: Health Care Stocks Advance Late Afternoon	Nov. 10	MT
America's markets lose their nerve	Nov. 07
NOVARTIS AG : UBS is Neutral	Nov. 04	ZD
NOVARTIS : UBS raises target price	Nov. 04
Morgan Stanley upgrades Novartis stock	Oct. 31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Novartis raises guidance and target price after strong execution

December 05, 2025 at 11:23 am EST

Novartis CEO Says They Will Have to 'Tackle Rhetoric' in US Healthcare

January 21, 2025 at 05:56 am EST